<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Articles</title>
	<atom:link href="https://www.worldpharmatoday.com/articles/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Fri, 12 Jun 2026 10:01:19 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>Articles</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>The Engine of Cell Therapy Success: Why Analytical Development Determines Whether Promising Cell Therapies Reach Patients</title>
		<link>https://www.worldpharmatoday.com/research-insight/the-engine-of-cell-therapy-success-why-analytical-development-determines-whether-promising-cell-therapies-reach-patients/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 12 Jun 2026 09:57:32 +0000</pubDate>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[BioPharma]]></category>
		<category><![CDATA[Research Insight]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/the-engine-of-cell-therapy-success-why-analytical-development-determines-whether-promising-cell-therapies-reach-patients/</guid>

					<description><![CDATA[<p>How advanced analytical methods, potency assays, and immune profiling are shaping the future of cancer cell therapies Cell therapies have transformed the treatment landscape for patients with cancer and other serious diseases. Innovations such as CAR-T cell therapies have demonstrated remarkable clinical success, offering new treatment options for patients with limited alternatives. While much of [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/research-insight/the-engine-of-cell-therapy-success-why-analytical-development-determines-whether-promising-cell-therapies-reach-patients/">The Engine of Cell Therapy Success: Why Analytical Development Determines Whether Promising Cell Therapies Reach Patients</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Stevanato Group and Syntegon Join Forces to Drive Innovation</title>
		<link>https://www.worldpharmatoday.com/articles/stevanato-group-and-syntegon-join-forces-to-drive-innovation/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 02 Jun 2026 13:27:06 +0000</pubDate>
				<category><![CDATA[Articles]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/stevanato-group-and-syntegon-join-forces-to-drive-innovation/</guid>

					<description><![CDATA[<p>Quality first: advanced manufacturing process for EZ-fill® cartridges The development of GLP-1 drugs has revolutionized the treatment of diabetes and obesity – and is a catalyst for breaking new grounds in ready-to-use cartridge manufacturing. Primary packaging provider Stevanato Group has teamed up with equipment supplier Syntegon to develop an advanced manufacturing process for Stevanato Group’s [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/articles/stevanato-group-and-syntegon-join-forces-to-drive-innovation/">Stevanato Group and Syntegon Join Forces to Drive Innovation</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Move Beyond Visibility: Why Cold Chain Orchestration is Now Essential for Thermal Assurance</title>
		<link>https://www.worldpharmatoday.com/articles/move-beyond-visibility-why-cold-chain-orchestration-is-now-essential-for-thermal-assurance/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Thu, 07 May 2026 12:00:58 +0000</pubDate>
				<category><![CDATA[Articles]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/move-beyond-visibility-why-cold-chain-orchestration-is-now-essential-for-thermal-assurance/</guid>

					<description><![CDATA[<p>As life sciences supply chains become more volatile, real-time visibility is increasingly the baseline for operational excellence. The next frontier is orchestration: turning fragmented signals into decisions that prevent excursions, reduce waste, and protect patients.  Sam Durham, Product Manager &#8211; Digital Solutions &#38; Services at Cold Chain Technologies, explains the role of digital technology in [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/articles/move-beyond-visibility-why-cold-chain-orchestration-is-now-essential-for-thermal-assurance/">Move Beyond Visibility: Why Cold Chain Orchestration is Now Essential for Thermal Assurance</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Speed in complex drug development is the late-phase outcome of early-phase decisions</title>
		<link>https://www.worldpharmatoday.com/articles/speed-in-complex-drug-development-is-the-late-phase-outcome-of-early-phase-decisions/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 17 Apr 2026 13:50:20 +0000</pubDate>
				<category><![CDATA[Articles]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/speed-in-complex-drug-development-is-the-late-phase-outcome-of-early-phase-decisions/</guid>

					<description><![CDATA[<p>Late-stage development is where timelines tighten, complexity increases, and the demand for speed becomes most visible. Execution is often treated as the lever—compressed timelines, parallel workstreams, faster decision-making. But speed is rarely created at that stage. It is shaped earlier, through decisions made when flexibility is still high and the cost of change is lower. [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/articles/speed-in-complex-drug-development-is-the-late-phase-outcome-of-early-phase-decisions/">Speed in complex drug development is the late-phase outcome of early-phase decisions</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>The Evolution of Field Execution in Specialty Pharma: From Coverage to Engagement</title>
		<link>https://www.worldpharmatoday.com/articles/the-evolution-of-field-execution-in-specialty-pharma-from-coverage-to-engagement/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 06 Apr 2026 08:17:20 +0000</pubDate>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Biopharmaceutical Development]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/the-evolution-of-field-execution-in-specialty-pharma-from-coverage-to-engagement/</guid>

					<description><![CDATA[<p>Why Field Execution Must Evolve Field execution — how pharma companies organize, direct, and deliver commercial and medical interactions with healthcare professionals (HCPs), prescribers, and institutional decision-makers (collectively, &#8220;customers&#8221;) — is a major contributor to commercial success. Accordingly, over the past decade, companies have invested heavily in sales force effectiveness, key account management, omnichannel strategies, [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/articles/the-evolution-of-field-execution-in-specialty-pharma-from-coverage-to-engagement/">The Evolution of Field Execution in Specialty Pharma: From Coverage to Engagement</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>4 Critical Peel Testing Parameters for Pharmaceutical Blister Packaging</title>
		<link>https://www.worldpharmatoday.com/packaging-labelling/4-critical-peel-testing-parameters-for-pharmaceutical-blister-packaging/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 03 Apr 2026 09:38:31 +0000</pubDate>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Packaging & Labelling]]></category>
		<category><![CDATA[Production & Manufacturing]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/4-critical-peel-testing-parameters-for-pharmaceutical-blister-packaging/</guid>

					<description><![CDATA[<p>A blister pack may seem like a simple enough concept until you’re trying to prove that it will open cleanly every time. Peel testing turns each peel into data so you can protect dose integrity, support and child resistance and avoid line surprises. What Peel Testing Measures Peel testing measures the force required to separate [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/packaging-labelling/4-critical-peel-testing-parameters-for-pharmaceutical-blister-packaging/">4 Critical Peel Testing Parameters for Pharmaceutical Blister Packaging</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Integrating high-voltage leak detection into automated visual inspection</title>
		<link>https://www.worldpharmatoday.com/articles/integrating-high-voltage-leak-detection-into-automated-visual-inspection/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 20 Mar 2026 11:21:51 +0000</pubDate>
				<category><![CDATA[Articles]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/integrating-high-voltage-leak-detection-into-automated-visual-inspection/</guid>

					<description><![CDATA[<p>The protection of patient health starts with ensuring the safety of pharmaceutical products even before they reach healthcare providers. Every recall caused by defective or leaking containers is one too many. As the pharmaceutical industry continues to evolve towards safer processes, a key trend is driving positive change: the growing demand for leak detection complementary [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/articles/integrating-high-voltage-leak-detection-into-automated-visual-inspection/">Integrating high-voltage leak detection into automated visual inspection</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Aligning Global Clinical Trials with Standardized Drug Data</title>
		<link>https://www.worldpharmatoday.com/articles/aligning-global-clinical-trials-with-standardized-drug-data/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 23 Feb 2026 06:18:42 +0000</pubDate>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[IT & Data Management]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/aligning-global-clinical-trials-with-standardized-drug-data/</guid>

					<description><![CDATA[<p>Modern drug development necessitates a shift from fragmented data silos to a unified, intelligence-driven framework. Achieving global regulatory alignment requires a sophisticated approach to trial documentation standards and pharmaceutical regulatory governance, ensuring that clinical trial design remains robust across multiple jurisdictions. By leveraging standardized drug intelligence, sponsors can enhance submission readiness and maintain cross-border compliance, ultimately accelerating the delivery of life-saving therapies to patients worldwide.</p>
The post <a href="https://www.worldpharmatoday.com/articles/aligning-global-clinical-trials-with-standardized-drug-data/">Aligning Global Clinical Trials with Standardized Drug Data</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Who are the Top Vendors for Budget-Friendly Laboratory Supplies?</title>
		<link>https://www.worldpharmatoday.com/articles/who-are-the-top-vendors-for-budget-friendly-laboratory-supplies/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 23 Dec 2025 13:17:54 +0000</pubDate>
				<category><![CDATA[Articles]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/who-are-the-top-vendors-for-budget-friendly-laboratory-supplies/</guid>

					<description><![CDATA[<p>Whether professionals need a high-performance gas chromatography system or a mass spectrometer, knowing where to look can help them stay under budget. The best sources for affordable lab equipment are used equipment dealers with online marketplaces. The Vetting Process for Selecting Lab Equipment Vendors For those looking for budget-friendly lab devices, fair prices are nonnegotiable. [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/articles/who-are-the-top-vendors-for-budget-friendly-laboratory-supplies/">Who are the Top Vendors for Budget-Friendly Laboratory Supplies?</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Future-proof vial filling &#8211; How flexibility Along the Line Defines Success</title>
		<link>https://www.worldpharmatoday.com/articles/future-proof-vial-filling-how-flexibility-along-the-line-defines-success/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 11 Oct 2025 07:24:09 +0000</pubDate>
				<category><![CDATA[Articles]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/future-proof-vial-filling-how-flexibility-along-the-line-defines-success/</guid>

					<description><![CDATA[<p>Vial fill-finish operations are changing faster than ever. New regulations such as the revised Annex 1 demand higher automation and less manual intervention, while new products – from large-scale vaccines to small-batch biologics – require significantly more flexible filling equipment and processes. Pharmaceutical manufacturers and CDMOs who want to remain competitive in the long-term need [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/articles/future-proof-vial-filling-how-flexibility-along-the-line-defines-success/">Future-proof vial filling – How flexibility Along the Line Defines Success</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
